![Jenny Tornqvist](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jenny Tornqvist
Nessuna posizione attualmente
Profilo
Dr. Jenny Tornqvist is a Manager-Clinical Project at Diffusion Pharmaceuticals LLC.
She received her undergraduate degree from Bryn Mawr College and a doctorate degree from the University of Virginia.
Precedenti posizioni note di Jenny Tornqvist
Società | Posizione | Fine |
---|---|---|
Diffusion Pharmaceuticals LLC
![]() Diffusion Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Diffusion Pharmaceuticals LLC develops and manufactures pharmaceutical products. The firm develops trans sodium crocetinate for use in cancers types in which tumor hypoxia (oxygen deprivation) is known to diminish the effectiveness of current treatments. The company was founded by Matthew W. Hantzmon, John L. Gainer, and David G. Kalergis in February 2001 and is headquartered in Charlottesville, VA. | Corporate Officer/Principal | - |
Formazione di Jenny Tornqvist
Bryn Mawr College | Undergraduate Degree |
University of Virginia | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Diffusion Pharmaceuticals LLC
![]() Diffusion Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Diffusion Pharmaceuticals LLC develops and manufactures pharmaceutical products. The firm develops trans sodium crocetinate for use in cancers types in which tumor hypoxia (oxygen deprivation) is known to diminish the effectiveness of current treatments. The company was founded by Matthew W. Hantzmon, John L. Gainer, and David G. Kalergis in February 2001 and is headquartered in Charlottesville, VA. | Health Technology |
- Borsa valori
- Insiders
- Jenny Tornqvist